No Data
No Data
10 Health Care Stocks With Whale Alerts In Today's Session
B.Riley Financial Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Cuts Target Price to $38
H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $80
Arrowhead Pharmaceuticals: Promising Drug Approval and Expanding Pipeline Justify Buy Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (EW), Arrowhead Pharmaceuticals (ARWR) and Exelixis (EXEL)
Morgan Stanley Maintains Arrowhead Pharmaceuticals(ARWR.US) With Hold Rating, Maintains Target Price $29